BioCardia, Inc.
BCDA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000925741
In the last 90 days, BioCardia, Inc. insiders filed 9 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in BioCardia, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- 0 vs. Q4 2025
- Shares held
- 686.6K
- +172.9K (+33.7%) vs. Q4 2025
- Total value
- $831.1K
- +$188.8K (+29.4%) vs. Q4 2025
- New holders
- 6
- 5 more added
- Sold out
- 6
- 2 more reduced
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $1.65M |
| Q1 2026 | 18 | $831.1K |
| Q4 2025 | 20 | $812.3K |
| Q3 2025 | 18 | $551.9K |
| Q2 2025 | 16 | $593.2K |
| Q1 2025 | 12 | $623.8K |
| Q4 2024 | 13 | $272.2K |
| Q3 2024 | 9 | $316.6K |
| Q2 2024 | 10 | $227.8K |
| Q1 2024 | 22 | $790.8K |
| Q4 2023 | 24 | $1.37M |
| Q3 2023 | 16 | $709.6K |
| Q2 2023 | 23 | $4.43M |
| Q1 2023 | 23 | $4.09M |
| Q4 2022 | 25 | $4.87M |
| Q3 2022 | 23 | $3.17M |
| Q2 2022 | 26 | $3.10M |
| Q1 2022 | 24 | $5.49M |
| Q4 2021 | 23 | $5.78M |
| Q3 2021 | 22 | $9.01M |
| Q2 2021 | 20 | $12.3M |
| Q1 2021 | 19 | $13.5M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding BioCardia, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CM Management, LLC | 130,000 | $157.3K | 0.13% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 124,591 | $150.8K | 0.00% | +124,591 | New |
| Geode Capital Management, LLC | 94,287 | $114.1K | 0.00% | +28,284+42.9% | Added |
| Vanguard Fiduciary Trust Co | 66,270 | $80.2K | 0.00% | +66,270 | New |
| Citadel Advisors LLC | 63,384 | $76.7K | 0.00% | −30,863−32.7% | Reduced |
| Susquehanna International Group, LLP | 38,827 | $47.0K | 0.00% | +180.0% | Added |
| Pingora Partners LLC | 35,739 | $43.2K | 0.03% | +32,703+1,077.2% | Added |
| Brown Advisory Inc | 35,538 | $43.0K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 24,270 | $29.4K | 0.00% | +7,980+49.0% | Added |
| Virtu Financial LLC | 20,355 | $25.0K | 0.00% | +20,355 | New |
| Commonwealth Equity Services, LLC | 18,283 | $22.1K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 14,780 | $17.9K | 0.00% | +14,780 | New |
| Renaissance Technologies LLC | 13,900 | $16.8K | 0.00% | +13,900 | New |
| Morgan Stanley | 3,105 | $3.76K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,978 | $3.60K | 0.00% | −316−9.6% | Reduced |
| Vanguard Global Advisers, LLC | 268 | $324 | 0.00% | +268 | New |
| SBI Securities Co., Ltd. | 9 | $11 | 0.00% | +3+50.0% | Added |
| Advisor Group Holdings, Inc. | 1 | $1 | 0.00% | 00.0% | Unchanged |
| DRW Securities, LLC | 0 | $0 | 0.00% | −57,607−100.0% | Sold out |
| Wealth Enhancement Advisory Services, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −11,229−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −11,303−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −4,423−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −469−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |